Minnesota Qualifying Conditions: Detailed Guide
What conditions qualify for medical marijuana in Minnesota?
Minnesota approves medical marijuana for 15+ qualifying conditions including chronic pain, PTSD, cancer, epilepsy, autism, and intractable pain. Even with recreational legalization in 2023, medical cards provide benefits like lower age requirements (18+ vs 21+) and tax savings. MMJ.com offers telehealth evaluations for $149.99 with same-day certification.## What is the complete list of Minnesota qualifying conditions?
Minnesota's Medical Marijuana Program, overseen by the Minnesota Department of Health, recognizes the following qualifying conditions for 2026:
Chronic Pain Conditions
- Intractable Pain (pain unresponsive to standard treatments)
- Chronic Pain
- Severe and Persistent Muscle Spasms
Neurological Conditions
- Seizures (including Epilepsy)
- Multiple Sclerosis (MS)
- Amyotrophic Lateral Sclerosis (ALS)
- Tourette's Syndrome
- Alzheimer's Disease
Mental Health and Developmental Conditions
- Post-Traumatic Stress Disorder (PTSD)
- Autism Spectrum Disorder
Cancer and Terminal Illness
- Cancer (with severe/chronic pain, nausea, or cachexia)
- Terminal Illness (life expectancy under one year)
- Cachexia/Wasting Syndrome
Gastrointestinal Conditions
- Inflammatory Bowel Disease (including Crohn's Disease)
Infectious Diseases
Eye Conditions
- Glaucoma
- Age-Related Macular Degeneration
Sleep Disorders
Blood Disorders
About the Qualifying Medical Conditions
Below is information about each qualifying condition and the research that informed Minnesota's decision to include it in the state program.
Chronic and Intractable Pain
Chronic and intractable pain are approved qualifying conditions under Minnesota's medical marijuana program. Minnesota included these conditions based on systematic reviews examining cannabinoid use among patients with chronic pain conditions.
Epilepsy and Seizure Disorders
Seizure disorders, including epilepsy, are approved qualifying conditions under Minnesota's medical marijuana program. Minnesota included these conditions based on clinical trial research examining CBD in patients with treatment-resistant epilepsy.
PTSD
PTSD is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on research examining cannabinoid use among patients with PTSD.
Cancer and Cachexia
Cancer and cachexia are approved qualifying conditions under Minnesota's medical marijuana program. Minnesota included these conditions based on research examining cannabinoid use among cancer patients experiencing treatment-related symptoms.
Multiple Sclerosis and ALS
MS and ALS are approved qualifying conditions under Minnesota's medical marijuana program. Minnesota included these conditions based on clinical research examining cannabinoid use in patients with spasticity and motor symptoms.
Autism Spectrum Disorder
Autism Spectrum Disorder is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on research examining cannabis use among patients with autism spectrum disorder.
Tourette's Syndrome
Tourette's Syndrome is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on research examining THC use in patients with Tourette's.
Inflammatory Bowel Disease
Inflammatory bowel disease, including Crohn's Disease, is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on clinical research examining cannabis use in IBD patients.
HIV/AIDS
HIV/AIDS is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on research examining cannabinoid use among HIV/AIDS patients.
Glaucoma
Glaucoma is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on early research examining the relationship between cannabinoids and intraocular pressure.
Age-Related Macular Degeneration
Age-Related Macular Degeneration is an approved qualifying condition under Minnesota's medical marijuana program as determined by the Minnesota Department of Health.
Obstructive Sleep Apnea
Obstructive Sleep Apnea is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on research examining cannabinoid use in sleep-disordered breathing.
Sickle Cell Disease
Sickle Cell Disease is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on research examining cannabis use among sickle cell patients.
Alzheimer's Disease
Alzheimer's Disease is an approved qualifying condition under Minnesota's medical marijuana program. Minnesota included this condition based on research examining cannabinoid use in dementia patients.
Can I petition for a new qualifying condition in Minnesota?
Yes, Minnesota has an annual petition process for adding new qualifying conditions:
- Petition Period: June-July each year
- Review Process: Minnesota Department of Health evaluates based on scientific evidence
- Decision Timeline: Typically by end of calendar year
- Recent Additions: Chronic pain, age-related macular degeneration, sickle cell disease
Medical Disclaimer
This page provides information about Minnesota's qualifying conditions for medical cannabis. The inclusion of a condition in Minnesota's program does not constitute medical advice or a guarantee of therapeutic benefit. Individual results vary. Potential side effects may include dizziness, sedation, and cognitive changes. Always consult a healthcare provider before starting treatment.
Reviewed by MMJ.com Medical Advisory Team Last Updated: December 17, 2025